Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
Open Access
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (10), 1065-1072
- https://doi.org/10.1016/j.bbmt.2006.06.006
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative GroupJournal of Clinical Oncology, 2001
- A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelBlood, 2001
- Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)Bone Marrow Transplantation, 2001
- Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.Journal of Clinical Oncology, 1997
- High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapyAnnals of Oncology, 1996
- High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsBlood, 1995
- Hodgkin's DiseaseNew England Journal of Medicine, 1992
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.Journal of Clinical Oncology, 1992
- Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988Blood, 1991
- Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell supportMedical and Pediatric Oncology, 1990